Related Experiment Videos
The optimal management of polycythaemia vera
1Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, MD, USA. jlspivak@mail.jhmi.edu
British Journal of Haematology
|February 14, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Myeloproliferative Neoplasms: Challenging Dogma.
Journal of clinical medicine·2024
Advances in polycythemia vera and lessons for acute leukemia.
Best practice & research. Clinical haematology·2021
The Thrombopoietin Receptor, MPL, Is a Therapeutic Target of Opportunity in the MPN.
Frontiers in oncology·2021
How I treat polycythemia vera.
Blood·2019
Cellular and molecular impacts of CELMoDs and IMiD on the induction of myeloid-derived suppressor cells by myeloma cells.
British journal of haematology·2026
In a nutshell: Haematological immune-related adverse events.
British journal of haematology·2026
The diagnosis and management of primary mediastinal B-cell lymphoma: A British Society for Haematology guideline.
British journal of haematology·2026
Increased anergic B cells and decreased antibody-secreting cells during romiplostim treatment in patients with immune thrombocytopenia.
British journal of haematology·2026
Distinct clinical and genetic characteristics of myelodysplastic syndrome in younger patients.
British journal of haematology·2026
Enhanced prognosis of acute myeloid leukaemia patients with dmCEBPAbZIP -inf mutations: Insights from a multicentre Chinese cohort study.
British journal of haematology·2026
Massive Biatrial Thrombus Formation 3 Decades After Heart Transplantation.
JACC. Case reports·2026
METTL7B Mitigates Hypertension and Vascular Remodeling.
Circulation·2026